MX2019006216A - Composicion oral solida que contiene colorantes. - Google Patents

Composicion oral solida que contiene colorantes.

Info

Publication number
MX2019006216A
MX2019006216A MX2019006216A MX2019006216A MX2019006216A MX 2019006216 A MX2019006216 A MX 2019006216A MX 2019006216 A MX2019006216 A MX 2019006216A MX 2019006216 A MX2019006216 A MX 2019006216A MX 2019006216 A MX2019006216 A MX 2019006216A
Authority
MX
Mexico
Prior art keywords
composition containing
oral composition
solid oral
containing dyes
colon
Prior art date
Application number
MX2019006216A
Other languages
English (en)
Inventor
Moro Luigi
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of MX2019006216A publication Critical patent/MX2019006216A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Endoscopes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invención se refiere a métodos para mejorar la detección de patologías en el colon y a un método para marcar las lesiones de la mucosa en el colon.
MX2019006216A 2016-11-28 2017-11-28 Composicion oral solida que contiene colorantes. MX2019006216A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662426903P 2016-11-28 2016-11-28
US201762587109P 2017-11-16 2017-11-16
PCT/EP2017/080574 WO2018096161A1 (en) 2016-11-28 2017-11-28 Solid oral composition containing dyes

Publications (1)

Publication Number Publication Date
MX2019006216A true MX2019006216A (es) 2019-08-22

Family

ID=60473539

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006216A MX2019006216A (es) 2016-11-28 2017-11-28 Composicion oral solida que contiene colorantes.

Country Status (12)

Country Link
US (2) US20180147301A1 (es)
EP (1) EP3544638A1 (es)
JP (1) JP2019535794A (es)
KR (1) KR20190090835A (es)
CN (1) CN110234359A (es)
AU (1) AU2017364274A1 (es)
BR (1) BR112019010691A2 (es)
CA (1) CA3043451A1 (es)
IL (1) IL266859A (es)
MX (1) MX2019006216A (es)
RU (1) RU2019118459A (es)
WO (1) WO2018096161A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900003113A1 (it) * 2019-03-04 2020-09-04 Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologna Bevanda coadiuvante
FR3104438B1 (fr) 2019-12-12 2021-11-19 Univ Bordeaux Formulation pour le bleu de methylene et procede

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431943B1 (en) 1999-06-14 2008-10-07 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical compositions
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
IT1398643B1 (it) 2010-03-04 2013-03-08 Cosmo Technologies Ltd Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
EP2722058A1 (en) * 2012-10-19 2014-04-23 Cosmo Technologies Ltd Solid oral composition containing dyes for use in endoscopic diagnosis

Also Published As

Publication number Publication date
US20180147301A1 (en) 2018-05-31
RU2019118459A3 (es) 2021-05-28
JP2019535794A (ja) 2019-12-12
AU2017364274A1 (en) 2019-05-30
BR112019010691A2 (pt) 2019-10-01
US20200061212A1 (en) 2020-02-27
CN110234359A (zh) 2019-09-13
CA3043451A1 (en) 2018-05-31
EP3544638A1 (en) 2019-10-02
IL266859A (en) 2019-07-31
KR20190090835A (ko) 2019-08-02
RU2019118459A (ru) 2020-12-28
WO2018096161A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
MX2017009532A (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
WO2015112896A3 (en) Methods and compositions for sequences guiding cas9 targeting
MX2017002514A (es) Composiciones de cuidado bucal y metodos de uso.
PH12018500659A1 (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
AR095977A1 (es) Un procedimiento para aumentar la formación de ácido piroglutámico de una proteína
EA202090683A3 (ru) Способы и композиции для лечения рака
MX2023012628A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
MX2017000776A (es) Polipeptidos fhbp meningococicos modificados.
MX2017008423A (es) Formulaciones transdérmicas.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2019000508A (es) Radioligandos para formar la imagen de la enzima indolamina 2,3-dioxigenasa (ido1).
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2019006216A (es) Composicion oral solida que contiene colorantes.
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
MX2021008225A (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
WO2016015055A8 (en) Colon cleansing compositions
MX2016008971A (es) Metodos de deteccion y cuantificacion de bacterias contenidas en o dentro de goma de mascar.
MX2016017136A (es) Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
MX2018004187A (es) Metodos y composiciones para prevenir o tratar cancer.
MX370192B (es) Metodos para analizar composiciones de cisteamina.
EA201692367A1 (ru) Сироп от кашля, содержащий амброксола гидрохлорид
MX2018006823A (es) Una composicion para mejorar la memoria, capacidad de aprendizaje y capacidad cognitiva.
EA201790117A1 (ru) Фармацевтическая композиция, содержащая 13 глицеридов, и ее препараты и их применение